Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatment

Bone Marrow Transplant. 2007 Sep;40(6):597-8. doi: 10.1038/sj.bmt.1705766. Epub 2007 Jul 9.

Authors

C Arber, A Buser, D Heim, M Weisser, A Tyndall, A Tichelli, J Passweg, A Gratwohl

PMID: 17618319
DOI: 10.1038/sj.bmt.1705766

No abstract available

Publication types

Case Reports
Comment
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Agammaglobulinemia / complications
Agammaglobulinemia / immunology
Agammaglobulinemia / pathology
Antibodies, Monoclonal / administration & dosage*
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents / administration & dosage*
Arthritis, Infectious / complications*
Arthritis, Infectious / immunology
Arthritis, Infectious / microbiology
B-Lymphocytes / pathology
Hematopoietic Stem Cell Transplantation*
Humans
Lymphoma, B-Cell / drug therapy
Lymphoma, B-Cell / pathology
Male
Rituximab
Ureaplasma Infections / complications*
Ureaplasma Infections / immunology
Ureaplasma urealyticum*

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Rituximab